BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olesen SW, Gerardin Y. Re-Evaluating the Evidence for Faecal Microbiota Transplantation ‘Super-Donors’ in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021;15:453-61. [DOI: 10.1093/ecco-jcc/jjaa170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Quraishi MN, Iqbal TH, Hart AL. Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet? J Crohns Colitis 2021;15:519-20. [PMID: 33079179 DOI: 10.1093/ecco-jcc/jjaa190] [Reference Citation Analysis]
2 Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo CJ, Gerardin Y, Crawford CV, Jacob V, Scherl E, Brown SE, Hambor J, Longman R. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation. Gastroenterology 2021:S0016-5085(21)03610-6. [PMID: 34606847 DOI: 10.1053/j.gastro.2021.09.061] [Reference Citation Analysis]
3 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
4 Núñez F P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00192-8. [PMID: 34118321 DOI: 10.1016/j.gastrohep.2021.05.009] [Reference Citation Analysis]